Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
3(60.0%)
Phase 4
2(40.0%)
5Total
N/A(3)
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT04694079Phase 4Completed

Ventricular Tachycardia Ablation and Myocardial Scar Characterization With Magnetic Resonance

Role: collaborator

NCT05842551Not ApplicableRecruiting

Prismatic Lenses and tDCS in Neglect

Role: collaborator

NCT07119827Recruiting

Personality Traits as a Variable in the Recovery of Patients With Acquired Brain Injury

Role: collaborator

NCT06736938Phase 4Not Yet Recruiting

Balanced Analgosedation in Bronchoscopy: Propofol/Pethidine Versus Midazolam/Pethidine

Role: collaborator

NCT04549831Recruiting

Genetic Bases of COVID-19 Clinical Variability

Role: collaborator

NCT04641585Not ApplicableUnknown

Brugada Syndrome and Artificial Intelligence Applications to Diagnosis

Role: collaborator

NCT04604171Not ApplicableCompleted

Action Observation Training for Upper Limb Recovery in Patients With Stroke

Role: lead

All 7 trials loaded